57962-007 : Imbruvica 70 mg/ml Oral Suspension


NDC57962-007
Labeler: Pharmacyclics LLC
Product Type: Human Prescription Drug
Drug Name:  Imbruvica
Dosage Form: Oral Suspension
Application #: NDA205552
Rev. Date: 


NDC Package Codes:

  • 57962-007-12: 150 ML IN 1 BOTTLE, GLASS (57962‑007‑12)

Active Ingredients:

  • Ibrutinib

Dosage Strength:

  • 70 mg/mL

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 57962-014 Imbruvica 140 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-070 Imbruvica 70 mg Oral Capsule by Pharmacyclics LLC
  • 57962-280 Imbruvica 280 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-420 Imbruvica 420 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-560 Imbruvica 560 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-140 Imbruvica (Ibrutinib 140 mg) by Pharmacyclics, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 57962-007 QR Code

< Prev: 57959-123Next: 57962-014 >

Related Discussions:

side effects with imbruvica
I have CLL/SLL with 11q deletion, recently I have been having several problems and cannot find the right information on ... 4 replies




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.